JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB9143

Anti-BRCA2 antibody

4

(1 Review)

|

(8 Publications)

Rabbit Polyclonal BRCA2 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Synthetic Peptide within Human BRCA2.

View Alternative Names

FACD, FANCD1, BRCA2, Breast cancer type 2 susceptibility protein, Fanconi anemia group D1 protein

2 Images
Immunoprecipitation - Anti-BRCA2 antibody (AB9143)
  • IP

Supplier Data

Immunoprecipitation - Anti-BRCA2 antibody (AB9143)

BRCA2 was immunoprecipitated from HEK293T whole cell lysate (1 mg per IP reaction, 20% loaded) with ab9143 at 6 μg per reaction. Western blot was performed on the immunoprecipitate using ab9143 at 0.01 μg/mL.

Lane 1 : ab9143 IP in HEK293T whole cell lysate.

Lane 2 : ab9143 IP in HEK293T whole cell lysate.

Lane 3 : Control IgG in HEK293T whole cell lysate.

Detection : Chemiluminescence with an exposure time of 30 seconds

All lanes:

Immunoprecipitation - Anti-BRCA2 antibody (ab9143)

Predicted band size: 384 kDa

false

Exposure time: 30s

Western blot - Anti-BRCA2 antibody (AB9143)
  • WB

Supplier Data

Western blot - Anti-BRCA2 antibody (AB9143)

All lanes:

Western blot - Anti-BRCA2 antibody (ab9143) at 0.1 µg/mL

Lane 1:

HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 50 µg

Lane 2:

OVCAR-3 (human ovary epithelial adenocarcinoma cell line) whole cell lysate at 50 µg

Lane 3:

HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 50 µg

Lane 4:

K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate at 50 µg

Lane 5:

Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 50 µg

Lane 6:

HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 50 µg

Lane 7:

U-2 OS (human bone osteosarcoma epithelial cell line) whole cell lysate at 50 µg

Lane 8:

MCF7 (human breast adenocarcinoma cell line) whole cell lysate at 50 µg

Predicted band size: 384 kDa

false

Exposure time: 3min

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP

applications

Immunogen

Synthetic Peptide within Human BRCA2. The exact immunogen used to generate this antibody is proprietary information.

P51587

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "2-10 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000 - 1/10000", "WB-species-notes": "<p></p>" }, "Chimpanzee": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Gorilla": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Antibodies were affinity purified using the peptide immobilized on solid support. Antibody concentration was determined by extinction coefficient: absorbance at 280 nmof 1.4 equals 1.0 mg of IgG.
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: PBS, 1.815% Tris, 1.764% Sodium citrate
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed : 24896180).
See full target information BRCA2

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:1568 PubMed38383600

2024

Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair.

Applications

Unspecified application

Species

Unspecified reactive species

Yumin Wang,Boya Gao,Luyuan Zhang,Xudong Wang,Xiaolan Zhu,Haibo Yang,Fengqi Zhang,Xueping Zhu,Badi Zhou,Sean Yao,Aiko Nagayama,Sanghoon Lee,Jian Ouyang,Siang-Boon Koh,Eric L Eisenhauer,Dominique Zarrella,Kate Lu,Bo R Rueda,Lee Zou,Xiaofeng A Su,Oladapo Yeku,Leif W Ellisen,Xiao-Song Wang,Li Lan

Journal of medical genetics : PubMed32482800

2020

Homozygous hypomorphic variant in primary ovarian insufficiency without cancer or Fanconi anaemia trait.

Applications

Unspecified application

Species

Unspecified reactive species

Sandrine Caburet,Abdelkader Heddar,Elodie Dardillac,Héléne Creux,Marie Lambert,Sébastien Messiaen,Sophie Tourpin,Gabriel Livera,Bernard S Lopez,Micheline Misrahi

Biomicrofluidics 12:054108 PubMed30344835

2018

Microfluidic platforms for rapid screening of cancer affinity reagents by using tissue samples.

Applications

Unspecified application

Species

Unspecified reactive species

Lien-Yu Hung,Chien-Yu Fu,Chih-Hung Wang,Yuan-Jhe Chuang,Yi-Cheng Tsai,Yi-Ling Lo,Pang-Hung Hsu,Hwan-You Chang,Shu-Chu Shiesh,Keng-Fu Hsu,Gwo-Bin Lee

Cancer research 76:2868-75 PubMed27013194

2016

Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest.

Applications

Unspecified application

Species

Unspecified reactive species

Lea Schaaf,Matthias Schwab,Christoph Ulmer,Simon Heine,Thomas E Mürdter,Jens O Schmid,Georg Sauer,Walter E Aulitzky,Heiko van der Kuip

Nature 528:422-6 PubMed26649820

2015

A mechanism for the suppression of homologous recombination in G1 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Alexandre Orthwein,Sylvie M Noordermeer,Marcus D Wilson,Sébastien Landry,Radoslav I Enchev,Alana Sherker,Meagan Munro,Jordan Pinder,Jayme Salsman,Graham Dellaire,Bing Xia,Matthias Peter,Daniel Durocher

Scientific reports 4:4258 PubMed24584735

2014

Inhibition of post-translational N-glycosylation by HRD1 that controls the fate of ABCG5/8 transporter.

Applications

Unspecified application

Species

Human

Shingo Suzuki,Tsuyoshi Shuto,Takashi Sato,Masayuki Kaneko,Tappei Takada,Mary Ann Suico,Douglas M Cyr,Hiroshi Suzuki,Hirofumi Kai

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27:3894-900 PubMed19620486

2009

Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers.

Applications

Unspecified application

Species

Unspecified reactive species

Patrice Watson,Rita Lieberman,Carrie Snyder,Vanessa J Clark,Henry T Lynch,Jeffrey T Holt

Human molecular genetics 12:2503-10 PubMed12915460

2003

Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.

Applications

ICC/IF

Species

Human

Shobbir Hussain,Emily Witt,Pia A J Huber,Annette L Medhurst,Alan Ashworth,Christopher G Mathew
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com